Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Baselga

Showing results (51-60 of 168) with videos related to

Pageof 17
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1997
Feasibility trial of high-dose 7-day continuous-infusion ifosfamide given on an outpatient basisJ Bellmunt, N Eres, A Ribas, et al.
Abdominal Imaging|January 14, 2005
Feasibility of CT scan-guided Tru-Cut serial liver biopsies to evaluate pharmacodynamic endpoints in patients with liver metastasis treated with experimental drugsA Hidalgo, J Tabernero, F Rojo, et al.
Journal of Colloid and Interface Science|July 28, 2004
Fluorescent labels to study thermal transitions in epoxy/silica compositesR Albalá, D Olmos, A J Aznar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2004
Targeted therapy in advanced colon cancer: the role of new therapiesJ Tabernero, R Salazar, E Casado, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 14, 2011
Pooled analysis of cardiac safety in patients with cancer treated with pertuzumabD Lenihan, T Suter, M Brammer, et al.
Investigational New Drugs|February 1, 1993
Phase II trial of gallium nitrate in previously treated patients with small cell lung cancerJ Baselga, M G Kris, H I Scher, et al.
Journal of Colloid and Interface Science|November 18, 2005
Effect of glass fiber surface treatments on mechanical strength of epoxy based composite materialsJ G Iglesias, J González-Benito, A J Aznar, et al.
Molecular Cell|May 7, 1999
A role for a PDZ protein in the early secretory pathway for the targeting of proTGF-alpha to the cell surfaceJ Fernández-Larrea, A Merlos-Suárez, J M Ureña, et al.
Cancer Research|March 30, 1999
Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cellsJ Codony-Servat, J Albanell, J C Lopez-Talavera, et al.
Cancer Research|June 15, 1992
Growth regulation of human renal carcinoma cells: role of transforming growth factor alphaI Atlas, J Mendelsohn, J Baselga, et al.
Pageof 17

Showing results (51-60 of 168) with videos related to

Sort By:
Pageof 17
Cancer Chemotherapy and Pharmacology|January 1, 1997
Feasibility trial of high-dose 7-day continuous-infusion ifosfamide given on an outpatient basisJ Bellmunt, N Eres, A Ribas, et al.
Abdominal Imaging|January 14, 2005
Feasibility of CT scan-guided Tru-Cut serial liver biopsies to evaluate pharmacodynamic endpoints in patients with liver metastasis treated with experimental drugsA Hidalgo, J Tabernero, F Rojo, et al.
Journal of Colloid and Interface Science|July 28, 2004
Fluorescent labels to study thermal transitions in epoxy/silica compositesR Albalá, D Olmos, A J Aznar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2004
Targeted therapy in advanced colon cancer: the role of new therapiesJ Tabernero, R Salazar, E Casado, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 14, 2011
Pooled analysis of cardiac safety in patients with cancer treated with pertuzumabD Lenihan, T Suter, M Brammer, et al.
Investigational New Drugs|February 1, 1993
Phase II trial of gallium nitrate in previously treated patients with small cell lung cancerJ Baselga, M G Kris, H I Scher, et al.
Journal of Colloid and Interface Science|November 18, 2005
Effect of glass fiber surface treatments on mechanical strength of epoxy based composite materialsJ G Iglesias, J González-Benito, A J Aznar, et al.
Molecular Cell|May 7, 1999
A role for a PDZ protein in the early secretory pathway for the targeting of proTGF-alpha to the cell surfaceJ Fernández-Larrea, A Merlos-Suárez, J M Ureña, et al.
Cancer Research|March 30, 1999
Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cellsJ Codony-Servat, J Albanell, J C Lopez-Talavera, et al.
Cancer Research|June 15, 1992
Growth regulation of human renal carcinoma cells: role of transforming growth factor alphaI Atlas, J Mendelsohn, J Baselga, et al.
Pageof 17